Board of Directors
Randeep Grewal (Chairman)
Randeep is a London-based ex-Fund manager with over 17 years of Healthcare investment experience including at Trium, F&C Asset Management, ICAP Equities and Tudor. Randeep trained as a Vascular and General Surgeon and read both Medicine and Computer Science at Cambridge University. He sits on the board of Tissue Regenix.
Josephine Dixon (Chair of the Audit Committee)
Josephine is a chartered accountant who sits on the boards of Standard Life Equity Income Trust plc, JP Morgan European Investment Trust plc, Strategic Equity Capital plc and F&C Global Smaller Companies Trust plc. Her executive experience includes finance, governance and general commercial roles in a number of sectors.
Prof. Justin Stebbing
Justin is a clinical oncologist and has published over 500 peer-reviewed papers on cancer. He is a Fellow of the Royal College of Physicians, the American Board of Internal Medicine and the Royal College of Pathologists and sits on a number of advisory boards. He also has previous investment management experience as a healthcare analyst.
Paul is a London-based Portfolio Manager at Pictet Asset Management, with over 21 years’ investment experience. Before joining Pictet, he was a Managing Partner at Eisenstat Capital Partners (ECAP) and managed European Equities for both Deephaven Capital and Fortress Investments Group. He began his career with UBS Asset Management.
Professor Tony Young
Tony is a practicing frontline NHS surgeon, Associate Medical Director at the Mid and South Essex University Hospitals Group, Director of Medical Innovation at Anglia Ruskin University. In 2014 he was appointed as National Clinical Director for Innovation at NHS England and in February 2016 became the first National Clinical Lead for Innovation. In 2015 he founded the NHS Clinical Entrepreneur programme. In 2019 Tony was awarded the OBE for services to clinical leadership.